In a promising development, the iGEM TU Eindhoven team, known for their innovation and excellence, has secured sponsorship from Pivot Park for iGEM’s groundbreaking project focused on tackling inflammatory bowel disease (IBD).
Last year, the iGEM TU Eindhoven team achieved a remarkable feat by clinching victory in the finals of the prestigious #IGEM Grand Jamboree. This year the 2023 team has set their sights on a vital healthcare challenge — IBD. This challenge afflicts approximately 4.9 million individuals worldwide, causing gut inflammation and debilitating symptoms.
The prevailing treatments for IBD present a significant challenge, as they impact the entire body, leading to undesirable side effects. The iGEM TU Eindhoven team recognizes this urgent need for improved treatment options and has embarked on a mission to design a revolutionary approach.
Their ambitious plan involves creating a modular platform comprising engineered probiotics that are both cost-effective and safe. This platform not only holds the potential to transform IBD treatment but also offers a versatile solution for a spectrum of bowel diseases.
About iGEM TU Eindhoven
iGEM TU Eindhoven is a student team that yearly participates in the world’s largest International Genetic Engineered Machine (iGEM) Competition (350+ teams, 40+ teams). Each year, the team tackles a real-world problem using genetic engineering and synthetic biology. Together with input from stakeholders we design, build, test, and measure a biological system using interchangeable biological parts and standard molecular biology techniques.